Psycheceutical Hosts MAPS Founder and Psychedelic Industry Leader Rick Doblin at Its…
<!-- Name:DistributionId Value:8798096 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
OTC Markets:BWVI
Psycheceutical Bioscience Provisional Patent Application for Novel Ketamine Topical…
MIAMI, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc ("Psycheceutical" or the "Company") (OTC: BWVI), a bioscience company dedicated to developing cutting-edge…
Psycheceutical Announces Julian Bailes, M.D. as Board Member and Chief Medical…
MIAMI, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc.(OTCPK: BWVI) ("Psycheceutical" or the "Company"), a bioscience company dedicated to developing cutting-edge brain…
Dr. Aric Logsdon Joins Psycheceutical Bioscience, Inc. as Company’s Scientific…
MIAMI, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc ("Psycheceutical" or the "Company") (OTC: BWVI), a bioscience company dedicated to developing cutting-edge…
Psycheceutical Bioscience, Inc. Announces Medical Advisory Board
MIAMI, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc ("Psycheceutical" or the "Company") (OTC: BWVI), a bioscience company dedicated to developing cutting-edge…